Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

Table of Contents

01 May 2016; volume 47, issue 5

Electronic resources

  • You have accessRestricted access
    ERJ May Podcast: using resting pulmonary artery pressure to predict abnormal exercise haemodynamics
    European Respiratory Journal 47 (5) E65; DOI: 10.1183/13993003.20164705.E65 Published 30 April 2016
    • ERJ Podcast

Editorials

  • You have accessRestricted access
    Blood eosinophil count: a biomarker of an important treatable trait in patients with airway disease
    Ian D. Pavord, Alvar Agusti
    European Respiratory Journal 47 (5) 1299-1303; DOI: 10.1183/13993003.00055-2016 Published 30 April 2016
    • Disclosures
  • You have accessRestricted access
    Is exhaled nitric oxide a marker of air pollution effect?
    Isabella Annesi-Maesano, Anh Tuan Dinh-Xuan
    European Respiratory Journal 47 (5) 1304-1306; DOI: 10.1183/13993003.00521-2016 Published 30 April 2016
  • You have accessRestricted access
    Are COPD and cardiovascular disease fundamentally intertwined?
    Mona Bafadhel, Richard E.K. Russell
    European Respiratory Journal 47 (5) 1307-1309; DOI: 10.1183/13993003.00399-2016 Published 30 April 2016
    • Disclosures
  • You have accessRestricted access
    Searching for the happy medium in the therapeutic approach to childhood sleep disordered breathing
    Francisco Campos-Rodriguez, Miguel A. Martínez-García
    European Respiratory Journal 47 (5) 1310-1312; DOI: 10.1183/13993003.00073-2016 Published 30 April 2016
  • You have accessRestricted access
    Guided duration of anticoagulation after unprovoked venous thromboembolism using D-dimer testing
    Francis Couturaud
    European Respiratory Journal 47 (5) 1313-1314; DOI: 10.1183/13993003.00212-2016 Published 30 April 2016
    • Disclosures
  • You have accessRestricted access
    Exercise pulmonary haemodynamics: a test in search of purpose
    J. Gerry Coghlan, Harm Jan Bogaard
    European Respiratory Journal 47 (5) 1315-1317; DOI: 10.1183/13993003.00397-2016 Published 30 April 2016
    • Disclosures
  • You have accessRestricted access
    Central pulmonary arteries in idiopathic pulmonary fibrosis: size really matters
    Laura C. Price, Anand Devaraj, S. John Wort
    European Respiratory Journal 47 (5) 1318-1320; DOI: 10.1183/13993003.00272-2016 Published 30 April 2016
    • Disclosures
  • You have accessRestricted access
    Targeted treatment of idiopathic pulmonary fibrosis: one step at a time
    Luca Richeldi
    European Respiratory Journal 47 (5) 1321-1323; DOI: 10.1183/13993003.00389-2016 Published 30 April 2016
    • Disclosures
  • You have accessRestricted access
    What's it like to live with idiopathic pulmonary fibrosis? Ask the experts
    Anne-Marie Russell, Jeffrey J. Swigris
    European Respiratory Journal 47 (5) 1324-1326; DOI: 10.1183/13993003.00109-2016 Published 30 April 2016
    • Disclosures
  • You have accessRestricted access
    Advancing global programmatic management of latent tuberculosis infection for at risk populations
    Haileyesus Getahun, Alberto Matteelli, Ibrahim Abubakar, Barbara Hauer, Emanuele Pontali, Giovanni Battista Migliori
    European Respiratory Journal 47 (5) 1327-1330; DOI: 10.1183/13993003.00449-2016 Published 30 April 2016
  • You have accessRestricted access
    The 5000% case: a glimpse into the financial issue of lung cancer treatment
    Jordi Remon, Julia Bonastre, Benjamin Besse
    European Respiratory Journal 47 (5) 1331-1333; DOI: 10.1183/13993003.00548-2016 Published 30 April 2016
    • Disclosures
  • You have accessRestricted access
    Toward better management of rare and orphan pulmonary diseases
    Sergio Harari, Marc Humbert
    European Respiratory Journal 47 (5) 1334-1335; DOI: 10.1183/13993003.00390-2016 Published 30 April 2016
    • Disclosures
  • You have accessRestricted access
    Increasing implementation and delivery of pulmonary rehabilitation: key messages from the new ATS/ERS policy statement
    Ioannis Vogiatzis, Carolyn L. Rochester, Martijn A. Spruit, Thierry Troosters, Enrico M. Clini  on behalf of the American Thoracic Society/European Respiratory Society Task Force on Policy in Pulmonary Rehabilitation
    European Respiratory Journal 47 (5) 1336-1341; DOI: 10.1183/13993003.02151-2015 Published 30 April 2016
  • You have accessRestricted access
    Clinical trials: registration and transparency
    Giovanni Sotgiu, Marc Humbert, Anh Tuan Dinh-Xuan, Giovanni Battista Migliori
    European Respiratory Journal 47 (5) 1342-1344; DOI: 10.1183/13993003.00479-2016 Published 30 April 2016

European Lung Corner

  • You have accessRestricted access
    Call for urgent actions to ensure access to early diagnosis and care of tuberculosis among refugees
    Masoud Dara, Ivan Solovic, Giovanni Sotgiu, Lia D'Ambrosio, Rosella Centis, Delia Goletti, Raquel Duarte, Stefano Aliberti, Fernando Maria de Benedictis, Graham Bothamley, Tom Schaberg, Ibrahim Abubakar, Brian Ward, Vitor Teixeira, Christina Gratziou, Giovanni Battista Migliori
    European Respiratory Journal 47 (5) 1345-1347; DOI: 10.1183/13993003.00377-2016 Published 30 April 2016
    • Disclosures

Original Articles

  • Air pollution and asthma

    • You have accessRestricted access
      Traffic-related air pollution and alveolar nitric oxide in southern California children
      Sandrah P. Eckel, Zilu Zhang, Rima Habre, Edward B. Rappaport, William S. Linn, Kiros Berhane, Yue Zhang, Theresa M. Bastain, Frank D. Gilliland
      European Respiratory Journal 47 (5) 1348-1356; DOI: 10.1183/13993003.01176-2015 Published 30 April 2016
      • Supplementary material
      • Disclosures
  • COPD

    • You have accessRestricted access
      Inflammatory bowel disease and risk of mortality in COPD
      Maria Vutcovici, Alain Bitton, Pierre Ernst, Abbas Kezouh, Samy Suissa, Paul Brassard
      European Respiratory Journal 47 (5) 1357-1364; DOI: 10.1183/13993003.01945-2015 Published 30 April 2016
    • You have accessRestricted access
      Circulating desmosine levels do not predict emphysema progression but are associated with cardiovascular risk and mortality in COPD
      Roberto A. Rabinovich, Bruce E. Miller, Karolina Wrobel, Kareshma Ranjit, Michelle C. Williams, Ellen Drost, Lisa D. Edwards, David A. Lomas, Stephen I. Rennard, Alvar Agustí, Ruth Tal-Singer, Jørgen Vestbo, Emiel F.M. Wouters, Michelle John, Edwin J.R. van Beek, John T Murchison, Charlotte E Bolton, William MacNee, Jeffrey T.J. Huang  on behalf of Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators
      European Respiratory Journal 47 (5) 1365-1373; DOI: 10.1183/13993003.01824-2015 Published 30 April 2016
      • Disclosures
      • Supplementary material
    • You have accessRestricted access
      Blood eosinophils as a marker of response to inhaled corticosteroids in COPD
      Neil C. Barnes, Raj Sharma, Sally Lettis, Peter M.A. Calverley
      European Respiratory Journal 47 (5) 1374-1382; DOI: 10.1183/13993003.01370-2015 Published 30 April 2016
      • Supplementary material
      • Disclosures
  • COPD and asthma

    • Open Access
      Serum periostin in obstructive airways disease
      James Fingleton, Irene Braithwaite, Justin Travers, Darren Bowles, Rianne Strik, Rob Siebers, Cecile Holweg, John Matthews, Mark Weatherall, Richard Beasley for the NZRHS Study Group
      European Respiratory Journal 47 (5) 1383-1391; DOI: 10.1183/13993003.01384-2015 Published 30 April 2016
      • Supplementary material
      • Disclosures
  • Cystic fibrosis

    • You have accessRestricted access
      Pseudomonas infection and mucociliary and absorptive clearance in the cystic fibrosis lung
      Landon W. Locke, Michael M. Myerburg, Daniel J. Weiner, Matthew R. Markovetz, Robert S. Parker, Ashok Muthukrishnan, Lawrence Weber, Michael R. Czachowski, Ryan T. Lacy, Joseph M. Pilewski, Timothy E. Corcoran
      European Respiratory Journal 47 (5) 1392-1401; DOI: 10.1183/13993003.01880-2015 Published 30 April 2016
      • Disclosures
      • Supplementary material
  • Sleep and paediatric pulmonology

    • You have accessRestricted access
      Natural history of sleep disordered breathing in prepubertal children transitioning to adolescence
      Edward O. Bixler, Julio Fernandez-Mendoza, Duanping Liao, Susan Calhoun, Sol M. Rodriguez-Colon, Jordan Gaines, Fan He, Alexandros N. Vgontzas
      European Respiratory Journal 47 (5) 1402-1409; DOI: 10.1183/13993003.01771-2015 Published 30 April 2016
      • Disclosures
  • Sleep

    • You have accessRestricted access
      Endoscopy evaluation to predict oral appliance outcomes in obstructive sleep apnoea
      Kentaro Okuno, Yasuhiro Sasao, Kanji Nohara, Takayoshi Sakai, Benjamin T. Pliska, Alan A. Lowe, C. Frank Ryan, Fernanda R. Almeida
      European Respiratory Journal 47 (5) 1410-1419; DOI: 10.1183/13993003.01088-2015 Published 30 April 2016
    • You have accessRestricted access
      Modafinil/armodafinil in obstructive sleep apnoea: a systematic review and meta-analysis
      Julia L. Chapman, Andrew Vakulin, Jan Hedner, Brendon J. Yee, Nathaniel S. Marshall
      European Respiratory Journal 47 (5) 1420-1428; DOI: 10.1183/13993003.01509-2015 Published 30 April 2016
      • Supplementary material
      • Disclosures
  • Pulmonary vascular diseases

    • You have accessRestricted access
      Duration of anticoagulation after isolated pulmonary embolism
      Gualtiero Palareti, Benilde Cosmi, Emilia Antonucci, Cristina Legnani, Nicoletta Erba, Angelo Ghirarduzzi, Daniela Poli, Sophie Testa, Alberto Tosetto, Vittorio Pengo, Paolo Prandoni  for the DULCIS investigators
      European Respiratory Journal 47 (5) 1429-1435; DOI: 10.1183/13993003.01126-2015 Published 30 April 2016
      • Disclosures
    • You have accessRestricted access
      Resting pulmonary artery pressure of 21–24 mmHg predicts abnormal exercise haemodynamics
      Edmund M.T. Lau, Laurent Godinas, Olivier Sitbon, David Montani, Laurent Savale, Xavier Jaïs, Frederic Lador, Sven Gunther, David S. Celermajer, Gérald Simonneau, Marc Humbert, Denis Chemla, Philippe Herve
      European Respiratory Journal 47 (5) 1436-1444; DOI: 10.1183/13993003.01684-2015 Published 30 April 2016
      • Supplementary material
      • Disclosures
      • ERJ Podcast
  • Pulmonary vascular diseases and interstitial lung diseases

    • You have accessRestricted access
      Pulmonary artery size as a predictor of outcomes in idiopathic pulmonary fibrosis
      Stephanie Shin, Christopher S. King, Nitin Puri, Oksana A. Shlobin, A. Whitney Brown, Shahzad Ahmad, Nargues A. Weir, Steven D. Nathan
      European Respiratory Journal 47 (5) 1445-1451; DOI: 10.1183/13993003.01532-2015 Published 30 April 2016
      • Supplementary material
      • Disclosures
  • Interstitial lung diseases

    • You have accessRestricted access
      Pulmonary rehabilitation in lymphangioleiomyomatosis: a controlled clinical trial
      Mariana S. Araujo, Bruno G. Baldi, Carolina S.G. Freitas, André L.P. Albuquerque, Cibele C.B. Marques da Silva, Ronaldo A. Kairalla, Celso R.F. Carvalho, Carlos R.R. Carvalho
      European Respiratory Journal 47 (5) 1452-1460; DOI: 10.1183/13993003.01683-2015 Published 30 April 2016
      • Supplementary material
    • You have accessRestricted access
      Predictors of objective cough frequency in pulmonary sarcoidosis
      Aish Sinha, Kai K. Lee, Gerrard F. Rafferty, Nadia Yousaf, Ian D. Pavord, James Galloway, Surinder S. Birring
      European Respiratory Journal 47 (5) 1461-1471; DOI: 10.1183/13993003.01369-2015 Published 30 April 2016
      • Supplementary material
      • Disclosures
    • You have accessRestricted access
      The lived experience with idiopathic pulmonary fibrosis: a qualitative study
      Dorthe Overgaard, Gudrun Kaldan, Kristoffer Marsaa, Thyge Lynghøj Nielsen, Saher Burhan Shaker, Ingrid Egerod
      European Respiratory Journal 47 (5) 1472-1480; DOI: 10.1183/13993003.01566-2015 Published 30 April 2016
      • Disclosures
    • You have accessRestricted access
      FG-3019 anti-connective tissue growth factor monoclonal antibody: results of an open-label clinical trial in idiopathic pulmonary fibrosis
      Ganesh Raghu, Mary Beth Scholand, João de Andrade, Lisa Lancaster, Yolanda Mageto, Jonathan Goldin, Kevin K. Brown, Kevin R. Flaherty, Mark Wencel, Jack Wanger, Thomas Neff, Frank Valone, John Stauffer, Seth Porter
      European Respiratory Journal 47 (5) 1481-1491; DOI: 10.1183/13993003.01030-2015 Published 30 April 2016
      • Disclosures
  • Tuberculosis

    • You have accessRestricted access
      Monitoring latent tuberculosis infection diagnosis and management in the Netherlands
      Connie G.M. Erkens, Erika Slump, Maurits Verhagen, Henrieke Schimmel, Gerard de Vries, Frank Cobelens, Susan van den Hof
      European Respiratory Journal 47 (5) 1492-1501; DOI: 10.1183/13993003.01397-2015 Published 30 April 2016
      • Supplementary material
  • Lung cancer

    • You have accessRestricted access
      Inequalities in lung cancer: a world of EGFR
      Mélodie Carbonnaux, Pierre-Jean Souquet, Anne-Pascale Meert, Arnaud Scherpereel, Matthew Peters, Sébastien Couraud
      European Respiratory Journal 47 (5) 1502-1509; DOI: 10.1183/13993003.01157-2015 Published 30 April 2016
      • Disclosures
      • Supplementary material
  • Lung imaging

    • You have accessRestricted access
      Outcome of incidentally detected airway nodules
      Hyung-Jun Kim, Deog Kyeom Kim, Young Whan Kim, Yeon Joo Lee, Jong Sun Park, Young-Jae Cho, Se Joong Kim, Ho Il Yoon, Jae Ho Lee, Choon-Taek Lee
      European Respiratory Journal 47 (5) 1510-1517; DOI: 10.1183/13993003.01992-2015 Published 30 April 2016
      • Supplementary material

Series

  • You have accessRestricted access
    Pulmonary veno-occlusive disease
    David Montani, Edmund M. Lau, Peter Dorfmüller, Barbara Girerd, Xavier Jaïs, Laurent Savale, Frederic Perros, Esther Nossent, Gilles Garcia, Florence Parent, Elie Fadel, Florent Soubrier, Olivier Sitbon, Gérald Simonneau, Marc Humbert
    European Respiratory Journal 47 (5) 1518-1534; DOI: 10.1183/13993003.00026-2016 Published 30 April 2016
    • Disclosures

State of the Art

  • You have accessRestricted access
    Connective tissue diseases, multimorbidity and the ageing lung
    Paolo Spagnolo, Jean-François Cordier, Vincent Cottin
    European Respiratory Journal 47 (5) 1535-1558; DOI: 10.1183/13993003.00829-2015 Published 30 April 2016
    • Disclosures

Agora

  • Research letters

    • You have accessRestricted access
      A comparison of COPD patients with and without ACOS in the ECLIPSE study
      Keele E. Wurst, Tara R. Rheault, Lisa Edwards, Ruth Tal-Singer, Alvar Agusti, Jørgen Vestbo
      European Respiratory Journal 47 (5) 1559-1562; DOI: 10.1183/13993003.02045-2015 Published 30 April 2016
      • Disclosures
    • You have accessRestricted access
      Blood eosinophil count to predict bronchial eosinophilic inflammation in COPD
      Florence Schleich, Jean-Louis Corhay, Renaud Louis
      European Respiratory Journal 47 (5) 1562-1564; DOI: 10.1183/13993003.01659-2015 Published 30 April 2016
    • You have accessRestricted access
      Can health status questionnaires be used as a measure of physical activity in COPD patients?
      Heleen Demeyer, Ivan Dueñas-Espín, Corina De Jong, Zafeiris Louvaris, Miek Hornikx, Elena Gimeno-Santos, Matthias Loeckx, Ioannis Vogiatzis, Wim Janssens, Nicholas S. Hopkinson, Roberto A. Rabinovich, Niklas Karlsson, Judith Garcia-Aymerich, Thierry Troosters on behalf of the PROactive consortium
      European Respiratory Journal 47 (5) 1565-1568; DOI: 10.1183/13993003.01815-2015 Published 30 April 2016
      • Disclosures
    • Open Access
      Urokinase plasminogen activator receptor polymorphisms and airway remodelling in asthma
      Despo Ierodiakonou, Michael A. Portelli, Dirkje S. Postma, Gerard H. Koppelman, Jorrit Gerritsen, Nick H.T. ten Hacken, Wim Timens, H. Marike Boezen, Judith M. Vonk, Ian Sayers
      European Respiratory Journal 47 (5) 1568-1571; DOI: 10.1183/13993003.01571-2015 Published 30 April 2016
      • Disclosures
    • You have accessRestricted access
      3-day mortality in hospitalised community-acquired pneumonia: frequency and risk factors
      Martin Kolditz, Torsten T. Bauer, Thomas König, Gernot Rohde, Santiago Ewig
      European Respiratory Journal 47 (5) 1572-1574; DOI: 10.1183/13993003.00113-2016 Published 30 April 2016
      • Disclosures
    • You have accessRestricted access
      Should all adult cystic fibrosis patients with repeated nontuberculous mycobacteria cultures receive specific treatment? A 10-year case–control study
      Christiane Albrecht, Felix Ringshausen, Sebastian Ott, Dirk Wagner, Jessica Rademacher, Michael Schneider, Tobias Welte, Mathias W. Pletz
      European Respiratory Journal 47 (5) 1575-1577; DOI: 10.1183/13993003.01239-2015 Published 30 April 2016
    • You have accessRestricted access
      High levels of neurological involvement but low mortality in miliary tuberculosis: a 6-year case-series from the UK
      Navin Venkatraman, Thomas King, David Bell, Gerrit Woltmann, Martin Wiselka, Ibrahim Abubakar, Manish Pareek
      European Respiratory Journal 47 (5) 1578-1581; DOI: 10.1183/13993003.01958-2015 Published 30 April 2016
    • You have accessRestricted access
      First experience of effectiveness and safety of bedaquiline for 18 months within an optimised regimen for XDR-TB
      Joseph M. Lewis, Paul Hine, Jenny Walker, Saye H. Khoo, Miriam Taegtmeyer, S. Bertel Squire, Derek J. Sloan
      European Respiratory Journal 47 (5) 1581-1584; DOI: 10.1183/13993003.01980-2015 Published 30 April 2016
      • Disclosures
    • You have accessRestricted access
      An overview on tuberculosis-specific hospitals in China in 2009: results of a national survey
      Yu Pang, Jian Du, Zhi Zhen Qin, Zoë Greenwald, Yuhong Liu, Fengling Mi, Yanlin Zhao, Liang Li
      European Respiratory Journal 47 (5) 1584-1587; DOI: 10.1183/13993003.01854-2015 Published 30 April 2016
    • You have accessRestricted access
      First independent evaluation of QuantiFERON-TB Plus performance
      Lucia Barcellini, Emanuele Borroni, James Brown, Enrico Brunetti, Luigi Codecasa, Federica Cugnata, Paola Dal Monte, Clelia Di Serio, Delia Goletti, Giulia Lombardi, Marc Lipman, Paola M.V. Rancoita, Marina Tadolini, Daniela M. Cirillo
      European Respiratory Journal 47 (5) 1587-1590; DOI: 10.1183/13993003.02033-2015 Published 30 April 2016
  • Correspondence

    • You have accessRestricted access
      Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in China
      Catherine Berry, Tom A. Yates, James A. Seddon, Patrick P. J. Phillips, Philipp du Cros on behalf of the North London TB Journal Club
      European Respiratory Journal 47 (5) 1591-1592; DOI: 10.1183/13993003.01646-2015 Published 30 April 2016
      • Disclosures
    • You have accessRestricted access
      Benefit of treatment of latent tuberculosis infection in individual patients
      Kyle Fluegge
      European Respiratory Journal 47 (5) 1592-1594; DOI: 10.1183/13993003.01946-2015 Published 30 April 2016
    • You have accessRestricted access
      Benefit of treatment of latent tuberculosis infection in individual patients
      Claudia C. Dobler, Andrew Martin, Guy B. Marks
      European Respiratory Journal 47 (5) 1594-1595; DOI: 10.1183/13993003.00175-2016 Published 30 April 2016
Back to top
PreviousNext
European Respiratory Journal: 47 (5)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author

Search Within This Issue

Jump to

  • Electronic resources
  • Editorials
  • European Lung Corner
  • Original Articles
    • Air pollution and asthma
    • COPD
    • COPD and asthma
    • Cystic fibrosis
    • Sleep and paediatric pulmonology
    • Sleep
    • Pulmonary vascular diseases
    • Pulmonary vascular diseases and interstitial lung diseases
    • Interstitial lung diseases
    • Tuberculosis
    • Lung cancer
    • Lung imaging
  • Series
  • State of the Art
  • Agora
    • Research letters
    • Correspondence
Manage Table of content Alerts
  • Most Read
  • Twitter
Loading
  • Pulsus paradoxus
  • ERS/ATS technical standard on interpretive strategies for routine lung function tests
  • European Respiratory Society guidelines for the diagnosis of asthma in adults
  • The association between SARS-CoV-2 RT-PCR cycle threshold and mortality in a community cohort
  • ERS clinical practice guidelines on treatment of sarcoidosis
More...

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society